Rocket Doctor AI

Rocket Doctor AI Enterprise Value

Delisted

The Enterprise Value (EV) of Rocket Doctor AI (TRUE.CN) as of Nov 16, 2026 is 69.20 M CAD. In the previous year, Enterprise Value (EV) was 70.15 M CAD — a change of -1.35% (lower).

Enterprise Value

69.20 MCAD

YoY

-1.35%

Last updated:

Enterprise Value (EV) of Rocket Doctor AI is 2024 69.20 M CAD. Enterprise Value (EV) of Rocket Doctor AI was 2023 70.15 M CAD. It decreases by -1.35% lower compared to the previous year.

The Rocket Doctor AI Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2017
70.27 M CAD
Jan 1, 2018
70.25 M CAD
Jan 1, 2019
69.76 M CAD
Jan 1, 2020
69.97 M CAD
Jan 1, 2021
69.36 M CAD
Jan 1, 2022
70.84 M CAD
Jan 1, 2023
70.15 M CAD
Jan 1, 2024
69.20 M CAD
The Rocket Doctor AI Enterprise Value history
YEAREnterprise ValueYoY
69.20 MCAD-1.35%
70.15 MCAD-0.98%
70.84 MCAD+2.13%
69.36 MCAD-0.86%
69.97 MCAD+0.29%
69.76 MCAD-0.70%
70.25 MCAD-0.02%
70.27 MCAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rocket Doctor AI Stock analysis

What does Rocket Doctor AI do? Treatment.com AI Inc generates revenue through its Treatment Digital Health App, a symptom assessment tool developed by a global team of doctors and engineers. The app provides predictive health insights using disease rate estimates, geographic variation data, and medical research, targeting patients and caregivers seeking informed health decisions. The company also offers medical education solutions and clinical advisor services, serving healthcare professionals and institutions globally. Revenue streams include subscriptions for app access and tailored medical education programs. The Treatment Digital Health App is designed for widespread use, offering advanced medical knowledge access to users worldwide. Medical clinic solutions are integrated into the platform, supporting healthcare providers in decision-making. Clinical advisor services leverage the AI platform to assist clinics and institutions with specialized medical guidance. These offerings are marketed to healthcare consumers, clinics, and educational institutions as part of the company's global healthcare technology strategy. Treatment.com AI Inc's business model focuses on AI-driven health solutions, with the Treatment Digital Health App as its primary product. The app's predictive health assessments are updated regularly by medical professionals, ensuring relevance and accuracy. The company monetizes through direct consumer subscriptions and B2B partnerships with medical clinics and educational providers, emphasizing global accessibility and evidence-based medical insights. Rocket Doctor AI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rocket Doctor AI stock

Enterprise Value (EV) of Rocket Doctor AI is 69.20 M CAD in 2024.

Enterprise Value (EV) of Rocket Doctor AI changed from 70.15 M CAD to 69.20 M CAD, representing a -1.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Rocket Doctor AI since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s CAD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' CAD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Rocket Doctor AI with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Rocket Doctor AI

All Key Metrics — Rocket Doctor AI